109 related articles for article (PubMed ID: 20627564)
1. Activity of substituted thiophene sulfonamides against malarial and mammalian cyclin dependent protein kinases.
Caridha D; Kathcart AK; Jirage D; Waters NC
Bioorg Med Chem Lett; 2010 Jul; 20(13):3863-7. PubMed ID: 20627564
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of Pfmrk, a Plasmodium falciparum CDK, by antimalarial 1,3-diaryl-2-propenones.
Geyer JA; Keenan SM; Woodard CL; Thompson PA; Gerena L; Nichols DA; Gutteridge CE; Waters NC
Bioorg Med Chem Lett; 2009 Apr; 19(7):1982-5. PubMed ID: 19250824
[TBL] [Abstract][Full Text] [Related]
3. A three-dimensional in silico pharmacophore model for inhibition of Plasmodium falciparum cyclin-dependent kinases and discovery of different classes of novel Pfmrk specific inhibitors.
Bhattacharjee AK; Geyer JA; Woodard CL; Kathcart AK; Nichols DA; Prigge ST; Li Z; Mott BT; Waters NC
J Med Chem; 2004 Oct; 47(22):5418-26. PubMed ID: 15481979
[TBL] [Abstract][Full Text] [Related]
4. Targeting malaria with specific CDK inhibitors.
Geyer JA; Prigge ST; Waters NC
Biochim Biophys Acta; 2005 Dec; 1754(1-2):160-70. PubMed ID: 16185941
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of broad spectrum protein kinase inhibitors to probe the architecture of the malarial cyclin dependent protein kinase Pfmrk.
Woodard CL; Keenan SM; Gerena L; Welsh WJ; Geyer JA; Waters NC
Bioorg Med Chem Lett; 2007 Sep; 17(17):4961-6. PubMed ID: 17588749
[TBL] [Abstract][Full Text] [Related]
6. Oxindole-based compounds are selective inhibitors of Plasmodium falciparum cyclin dependent protein kinases.
Woodard CL; Li Z; Kathcart AK; Terrell J; Gerena L; Lopez-Sanchez M; Kyle DE; Bhattacharjee AK; Nichols DA; Ellis W; Prigge ST; Geyer JA; Waters NC
J Med Chem; 2003 Aug; 46(18):3877-82. PubMed ID: 12930149
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of 3,5-diaminoindazoles as cyclin-dependent kinase inhibitors.
Lee J; Choi H; Kim KH; Jeong S; Park JW; Baek CS; Lee SH
Bioorg Med Chem Lett; 2008 Apr; 18(7):2292-5. PubMed ID: 18353638
[TBL] [Abstract][Full Text] [Related]
8. Variolin B and its derivate deoxy-variolin B: new marine natural compounds with cyclin-dependent kinase inhibitor activity.
Simone M; Erba E; Damia G; Vikhanskaya F; Di Francesco AM; Riccardi R; Bailly C; Cuevas C; Fernandez Sousa-Faro JM; D'Incalci M
Eur J Cancer; 2005 Oct; 41(15):2366-77. PubMed ID: 16181779
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and antimalarial activity of benzene and isoquinoline sulfonamide derivatives.
Kumar Parai M; Panda G; Srivastava K; Kumar Puri S
Bioorg Med Chem Lett; 2008 Jan; 18(2):776-81. PubMed ID: 18039570
[TBL] [Abstract][Full Text] [Related]
10. Identification of an effector protein and gain-of-function mutants that activate Pfmrk, a malarial cyclin-dependent protein kinase.
Chen Y; Jirage D; Caridha D; Kathcart AK; Cortes EA; Dennull RA; Geyer JA; Prigge ST; Waters NC
Mol Biochem Parasitol; 2006 Sep; 149(1):48-57. PubMed ID: 16737745
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of the Plasmodium falciparum PK5 ATP-binding site: implications for the design of novel antimalarial agents.
Keenan SM; Welsh WJ
J Mol Graph Model; 2004 Jan; 22(3):241-7. PubMed ID: 14629982
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase inhibitors. Inhibition of Plasmodium falciparum carbonic anhydrase with aromatic sulfonamides: towards antimalarials with a novel mechanism of action?
Krungkrai J; Scozzafava A; Reungprapavut S; Krungkrai SR; Rattanajak R; Kamchonwongpaisan S; Supuran CT
Bioorg Med Chem; 2005 Jan; 13(2):483-9. PubMed ID: 15598570
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological activity of N-aryl-2-aminothiazoles: potent pan inhibitors of cyclin-dependent kinases.
Misra RN; Xiao HY; Williams DK; Kim KS; Lu S; Keller KA; Mulheron JG; Batorsky R; Tokarski JS; Sack JS; Kimball SD; Lee FY; Webster KR
Bioorg Med Chem Lett; 2004 Jun; 14(11):2973-7. PubMed ID: 15125971
[TBL] [Abstract][Full Text] [Related]
14. Antimalarial activity of compounds comprising a primary benzene sulfonamide fragment.
Andrews KT; Fisher GM; Sumanadasa SD; Skinner-Adams T; Moeker J; Lopez M; Poulsen SA
Bioorg Med Chem Lett; 2013 Nov; 23(22):6114-7. PubMed ID: 24084158
[TBL] [Abstract][Full Text] [Related]
15. p42/p44 MAPKs are intracellular targets of the CDK inhibitor purvalanol.
Knockaert M; Lenormand P; Gray N; Schultz P; Pouysségur J; Meijer L
Oncogene; 2002 Sep; 21(42):6413-24. PubMed ID: 12226745
[TBL] [Abstract][Full Text] [Related]
16. 3-Acyl-2,6-diaminopyridines as cyclin-dependent kinase inhibitors: synthesis and biological evaluation.
Lin R; Lu Y; Wetter SK; Connolly PJ; Turchi IJ; Murray WV; Emanuel SL; Gruninger RH; Fuentes-Pesquera AR; Adams M; Pandey N; Moreno-Mazza S; Middleton SA; Jolliffe LK
Bioorg Med Chem Lett; 2005 May; 15(9):2221-4. PubMed ID: 15837297
[TBL] [Abstract][Full Text] [Related]
17. Chemical stability of the peroxide bond enables diversified synthesis of potent tetraoxane antimalarials.
Opsenica I; Opsenica D; Smith KS; Milhous WK; Solaja BA
J Med Chem; 2008 Apr; 51(7):2261-6. PubMed ID: 18330976
[TBL] [Abstract][Full Text] [Related]
18. Antimalarial and antitrypanosomal activity of a series of amide and sulfonamide derivatives of a 2,5-diaminobenzophenone.
Altenkämper M; Bechem B; Perruchon J; Heinrich S; Mädel A; Ortmann R; Dahse HM; Freunscht E; Wang Y; Rath J; Stich A; Hitzler M; Chiba P; Lanzer M; Schlitzer M
Bioorg Med Chem; 2009 Nov; 17(22):7690-7. PubMed ID: 19819706
[TBL] [Abstract][Full Text] [Related]
19. Exploration of a new type of antimalarial compounds based on febrifugine.
Kikuchi H; Yamamoto K; Horoiwa S; Hirai S; Kasahara R; Hariguchi N; Matsumoto M; Oshima Y
J Med Chem; 2006 Jul; 49(15):4698-706. PubMed ID: 16854076
[TBL] [Abstract][Full Text] [Related]
20. Cyclin-dependent protein kinases as therapeutic drug targets for antimalarial drug development.
Waters NC; Geyer JA
Expert Opin Ther Targets; 2003 Feb; 7(1):7-17. PubMed ID: 12556199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
